A new drug to treat Alzheimer’s Disease has been approved by Health Canada and it is the first drug that targets an ...

Lecanemab is the first medication approved in Canada that targets the buildup of amyloid plaque in the brain, which is ...

Alzheimer's disease is a progressive neurological disorder characterised by memory loss and cognitive decline, caused by ...

On Real Possibilities with AARP Michigan, associate professor of translational neuroscience Dr. Scott Counts from Michigan ...

A new vitamin K-based treatment could help replenish lost neurons in Alzheimer's patients, offering hope for slowing ...

Lewy Body Dementia (LBD) is a brain disease that’s often misunderstood. It’s actually the second most common type of ...

A group of researchers have identified a warning sign of Alzheimer's disease that can appear 25 years before other symptoms - ...

Michael Borrie, physician and medical director of the Aging and Memory Clinic at St. Joseph’s Health Care London, said Health ...

A study published in 2023 found that using sleeping pills to get some shut-eye could reduce the buildup of toxic clumps of ...

Doug Whitney, 76, carries a rare PSEN2 genetic mutation that causes early-onset Alzheimer's but shows no cognitive decline ...

Scientists have uncovered a toxic alliance between Aβ and fibrinogen that may explain how Alzheimer’s disease begins. The two ...

"Medical Journeys" is a set of clinical resources reviewed by physicians, meant for the medical team as well as the patients they serve. Each episode of this journey through a disease state contains ...